EquityFolio

INVA

NASDAQ HEALTHCARE

Innoviva Inc

$20.74

$0.08 (+0.39%)

Live quote

52w: $16.52 – $25.15

Loading chart…
P/E Ratio5.39
P/B Ratio1.19
EV/EBITDA—
Debt/Equity—
ROE21.99%
ROIC—
Revenue Growth14.67%
Gross Margin74.80%
Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.

Own INVA? Track it here.

Create a free account to add INVA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account